Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.
Also called NCT01587651
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 110 participants
- Registry
-
NCT01587651
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01587651. Randomized; no masking; primary purpose treatment. Start 2012-03 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2014-04-29.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
- Acronym
- SWAP-2
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Prasugrel Loading Dose
- Intervention (Drug)
- Prasugrel Maintenance Dose
- Intervention (Drug)
- Ticagrelor Maintenance Dose
- Lead sponsor
- Daiichi Sankyo
- Collaborator
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01587651- Content hash
faf85fb1f2e319c6a124ca57c5ad5fa240f05201e05cd4ae4cbc3a6c9afc3ed8